Many women are told that lab work is normal while symptoms keep getting louder. Weight-loss resistance can worsen even with a normal A1C. Mood can crash before a period even when routine testing shows nothing unusual. Anxiety can intensify after birth and still be brushed aside as part of new motherhood. Digestive symptoms can flare every luteal phase and still get labeled as nothing more than hormones.
This Hormone AMA focuses on the gap between what patients feel and what standard care often catches. I walk through the patterns that tend to show up before a formal diagnosis appears on paper. Instead of treating these issues as separate problems, I connect insulin signaling, inflammation, progesterone, thyroid function, the gut, and the nervous system.
That framing matters because many women are not being ignored by a single uncaring clinician. They are being managed inside a system that often waits for disease to become obvious before offering answers. This episode explains what can be happening earlier, what questions may move the conversation forward, and which warning signs should never be brushed off.
What This Episode Covers
- Why fasting insulin can rise before glucose and A1C become abnormal
- Why normal labs do not always rule out early metabolic dysfunction
- How sleep, stress, inflammation, PCOS, perimenopause, and sleep apnea can all affect insulin resistance
- Why waist-to-hip ratio, CRP, thyroid testing, cortisol, and an oral glucose tolerance test may add useful context
- What separates PMS from PMDD
- Why PMDD is not simply “bad PMS”
- When SSRIs may be appropriate during the luteal phase
- Why endometriosis can intensify anxiety, depression, pain, and sleep disruption
- How cytokines, prostaglandins, and histamine may shape mood symptoms in the luteal phase
- Why progesterone with fibroids is an individualized decision, not a blanket rule
- How fibroid size, location, bleeding pattern, and fertility goals affect treatment choices
- What postpartum anxiety and depression can have to do with progesterone withdrawal and allopregnanolone
- Why postpartum thyroiditis is frequently missed
- Which postpartum labs may matter when symptoms do not improve
- Why oral micronized progesterone is different from a progestin
- How luteal-phase digestive shifts can affect people with IBD
- Which food and supplement strategies may be gentler during the luteal phase
- Which red-flag symptoms mean it may be more than just hormones
Why the Doctor May Not Be Ignoring the Patient — But the System Is
One of the clearest themes in this episode is that a patient can feel terrible while standard testing still looks acceptable. That mismatch does not mean the symptoms are imagined. It often means the testing model is designed to catch disease later rather than dysfunction earlier.
I use fasting insulin as one of the clearest examples. Glucose and A1C may remain in range for a long time while insulin is already climbing. By the time glucose finally rises, the underlying metabolic strain may have been present for years. A patient can be told that everything is normal while the body is already working much harder than it should.
That same pattern shows up across hormone medicine. Reference ranges are built to identify overt disease, not always the early physiology behind stubborn symptoms. A woman with weight-loss resistance, cravings, fatigue, and central weight gain may need more than a quick glance at glucose. A woman with severe mood symptoms before a period may need more than reassurance that premenstrual changes are common. A new mother with panic, insomnia, and a sense that something is deeply off may need thyroid testing and endocrine evaluation, not only encouragement to rest.
The practical message in this section is not that standard medicine has nothing to offer. It is that patients often need a broader workup when the story and the labs do not match. I point to useful clues such as waist-to-hip ratio, inflammatory markers like CRP, a full thyroid panel, cortisol patterns when clinically relevant, and in some cases an oral glucose tolerance test. Those steps do not replace clinical judgment. They simply respect the fact that physiology usually changes before the chart says it has permission to count.
PMS, PMDD, and the Role of SSRIs in the Luteal Phase
This Hormone AMA also makes an important distinction between PMS and PMDD. PMS can include moodiness, irritability, bloating, and fatigue. PMDD is different in severity, impact, and likely mechanism. When severe premenstrual mood symptoms — including depression, anxiety, or thoughts of self-harm — arrive with a consistent luteal-phase pattern, that deserves a far more serious conversation than most conventional care offers.
I explain PMDD as a condition tied less to having abnormal hormone levels and more to how the brain responds to normal hormonal changes. The conversation highlights GABA receptor dysfunction and hormone sensitivity as key parts of the picture. That framing helps explain why some patients feel as if the luteal phase changes their entire personality even when conventional testing does not reveal an obvious endocrine disorder.
The episode also addresses treatment without stigma. In the episode, I point to current ACOG guidelines that include serotonergic medications for premenstrual disorders, and SSRIs can be especially helpful when used only in the luteal phase rather than every day. That matters because many patients have been told that an SSRI is only for major depression or that taking one means the problem is not hormonal. I reject that false divide. In PMDD, an SSRI can be a targeted, time-specific tool, and for some patients it can be lifesaving.
At the same time, the episode does not suggest SSRIs are the answer for every rough luteal phase. The distinction between PMS and PMDD still matters. So does the clinical context. Endometriosis may intensify premenstrual mood symptoms through inflammation, pain, sleep disruption, histamine, cytokines, and prostaglandins. When endometriosis and PMDD overlap, the patient may not be dealing with one disorder that needs one treatment. She may be carrying two separate but interacting burdens.
The point here is straightforward: severe luteal-phase symptoms are not weakness, overreaction, or a character flaw. They are a medical issue with real neurobiology behind them, and they deserve the same seriousness as any other condition that places a patient at risk.
Endometriosis, Fibroids, and Progesterone — What Actually Helps
The question of progesterone becomes much more complicated when fibroids and endometriosis enter the picture, and this episode stays with that complexity. I do not present progesterone as automatically protective or automatically harmful. I frame the decision the way it should be framed: by looking at the tissue involved, the symptoms in front of the clinician, and the goal of treatment.
That nuance matters because both endometriosis and fibroids are hormone-responsive conditions, and they often occur together. The episode notes that co-occurrence is common, which means many women are trying to make treatment decisions while managing more than one diagnosis at the same time. A therapy that helps one problem may affect the other, so a broad rule is rarely enough.
Endometriosis is described as far more than a reproductive condition. Lesions can become especially active in the luteal phase and produce inflammatory substances such as cytokines, prostaglandins, and histamine. Those chemicals do not stay neatly confined to pelvic pain. They can worsen fatigue, depression, anxiety, sleep quality, and even the way the brain processes stress. Treating endometriosis as only a gynecologic problem misses its full-body effects.
Fibroids add another layer because both estrogen and progesterone can influence fibroid growth. That does not mean progesterone should never be used. It means the answer depends on details. A patient with submucosal fibroids and heavy bleeding may have a different risk-benefit profile than a patient with large fibroids causing bulk symptoms and pelvic pressure. Route, dose, symptom pattern, fertility goals, and imaging findings all matter.
My practical advice centers on monitoring rather than slogans. Baseline imaging can help establish what is already present before therapy begins. Symptom tracking can show whether bleeding, pain, pressure, or cycle changes are improving or getting worse. Repeat imaging can help determine whether fibroids appear stable or whether growth is becoming more concerning. If estrogen therapy is also part of the picture and fibroids continue to enlarge, the discussion may need to shift toward procedural or surgical options.
This section also corrects a common oversimplification in hormone medicine. Progesterone is not a moral good, and fibroids are not proof that every hormone is dangerous. The better question is whether the treatment is serving the patient in front of the clinician. For some women, progesterone may help bleeding or support other hormone goals. For others, it may not solve the main problem at all. A large fibroid causing bulk symptoms is unlikely to disappear because progesterone was added. That patient may need a different conversation entirely.
The larger lesson is that individualized care is not indecision. It is appropriate medicine. When fibroids, endometriosis, mood symptoms, pain, and fertility goals all overlap, a simple yes-or-no answer usually hides more than it reveals.
Postpartum Anxiety and Depression — What Should Be Tested
The postpartum part of this Hormone AMA may be the most urgent. I treat postpartum anxiety and depression as real medical problems that deserve prompt attention, and I highlight how often biological contributors are missed.
One of the main mechanisms discussed is the sudden loss of placental hormones after birth. Progesterone drops rapidly, and that affects allopregnanolone, a neurosteroid that interacts with the GABA system. For some women, that shift can feel destabilizing almost immediately. Anxiety, insomnia, panic, agitation, or a sense of being unlike oneself can emerge even when everyone around them insists that the experience is normal.
The episode also stresses that postpartum mood symptoms should not automatically be treated as psychiatric in isolation. Thyroid disease can look remarkably similar. Postpartum thyroiditis is especially important because it often goes unrecognized. Early on, a woman may appear hyperthyroid — feeling unusually energized, anxious, or like the so-called “super mom” who doesn't need sleep. Later, the pattern can flip toward hypothyroid symptoms such as depression, lethargy, weight gain, and low milk supply. If no one checks thyroid labs, both phases can be misread.
That is why the lab discussion here matters. In the episode, I discuss a postpartum workup that may include a CBC, ferritin, TSH, free T4, free T3, thyroid antibodies such as TPOAb and TgAb, vitamin D, and B12. These tests do not explain every postpartum mental health struggle, but they can identify contributors that change treatment decisions. In a patient with treatment-resistant anxiety or depression after birth, checking thyroid function before piling on more psychiatric medication can be a critical step.
The episode also distinguishes oral micronized progesterone from synthetic progestins. That difference matters. Micronized progesterone may come up in selected postpartum conversations after milk supply is established, but it is not interchangeable with a progestin and it is not a replacement for full mental health care. The larger point is that hormone withdrawal can be one contributor among several.
I also touch on recovery basics that can affect how a patient feels after birth, especially when blood loss, poor sleep, and the demands of infant care are part of the picture. Magnesium glycinate, iron repletion when ferritin is low or bleeding was significant, and nutrients such as omega-3s, vitamin D, and B12 all come up in the episode. None of those basics should be used to minimize serious symptoms. They are part of basic physiology, not a substitute for urgent care when danger signs are present.
And the danger signs matter. Intrusive thoughts, paranoia, hallucinations, extreme insomnia, or signs that a mother is losing touch with reality point toward postpartum psychosis, which is a medical emergency. This is not an area for delay, watchful waiting, or casual reassurance. The episode is clear that maternal health is not optional.
Luteal Phase and the Gut — IBD-Safe Strategies
Digestive changes across the menstrual cycle are another area where patients are often dismissed. I explain that the cycle can absolutely influence the gut. Progesterone tends to slow motility during the luteal phase, which may increase constipation, bloating, or a sense of sluggish digestion. Closer to bleeding, prostaglandins rise and can trigger cramping and looser stools. Many women recognize this pattern immediately once it is named.
But this section also carries an important warning: cyclical timing does not prove that a symptom is harmless. That is especially true for patients with inflammatory bowel disease. In that setting, it is not safe to assume that every flare in diarrhea, pain, or bloating is only hormone-related. Blood in the stool, nocturnal diarrhea, fever, weight loss, anemia, or pain that is escalating rather than settling should trigger a closer look for active disease.
The practical strategies in this part of the episode stay close to daily life. Cooked vegetables may be easier to tolerate than large raw salads during the luteal phase. Smaller meals can reduce digestive burden. Bone broth and collagen protein may feel gentler during flares. Magnesium glycinate is usually easier than magnesium citrate for patients who are already prone to diarrhea. Ginger may help nausea or sluggish digestion, while peppermint oil can help spasms for some patients, though reflux needs to be considered.
I also mention omega-3s and vitamin D for immune support, and I note that a temporary low-FODMAP approach may help some patients when bloating is linked to SIBO or SIFO. At the same time, the episode warns that NSAIDs can aggravate IBD, and hormonal birth control may worsen symptoms for some individuals. The key takeaway is balance: cycle-related gut changes are real, but red flags still matter.
The Bigger Message From This Hormone AMA
Across every topic in this episode, the same pattern appears again and again. Patients are often told that symptoms are normal, unrelated, or not serious enough to investigate. I argue that these symptoms usually do have a pattern, and once that pattern is recognized, the next step becomes clearer.
High fasting insulin can matter even with normal glucose. Severe luteal-phase symptoms can reflect PMDD rather than routine PMS. Endometriosis can affect mood because inflammation changes far more than pelvic pain. Progesterone decisions with fibroids require monitoring, not a slogan. Postpartum anxiety may call for thyroid testing, nutrient repletion, psychiatric support, hormone evaluation, or all of the above. Digestive symptoms near a period may be cyclical, but they still deserve proper caution when IBD or other red flags are present.
What this Hormone AMA offers is language for experiences that are often minimized. It does not promise a single fix. It offers something more useful: a clearer map of what may be happening, which questions deserve better answers, and where the medical system most often asks patients to wait too long.
This Episode is Sponsored By
Dr. Brighten Essentials
Want science-backed supplements formulated by a doctor who actually understands women’s health? 🌿 At Dr. Brighten Essentials, every product is crafted to support your hormones, boost your energy, and help you feel your best—inside and out. From targeted nutrients for glowing skin to essentials that fuel your daily vitality, you’ll get the highest-quality ingredients in forms your body can truly use.
Exclusive for podcast listeners: Use code POD15 at checkout for 15% off your order.
HigherDOSE – Red Light Showerhead Filter
Your shower water could be impacting your skin more than you think. The HigherDOSE Red Light Showerhead Filter features a 10-stage filtration system designed to reduce chlorine, VOCs, and other contaminants that can contribute to dryness and irritation. It also includes built-in red light therapy to support cellular energy and overall skin appearance—turning your daily shower into a more restorative ritual.
Save 15% at higherdose.com/drbrighten and use code DRBRIGHTEN15 for 15% off
LMNT Electrolytes
Want a clean, science-backed way to stay hydrated and energized? At LMNT, electrolytes are formulated with a precise balance of sodium, potassium, and magnesium — with no sugar, no artificial ingredients, and no unnecessary fillers. Designed to support hydration, muscle function, and daily energy, LMNT helps you feel your best through workouts, busy days, and everyday life.
Exclusive for podcast listeners: Visit DrinkLMNT.com/Brighten to receive a free sample pack with any purchase.
Links Mentioned in This Episode
- Dr. Brighten perimenopause plan
- Book: Healing Your Body Naturally After Childbirth
- Book announcement: ADHD in Women (pre-order)
Related Articles
- PMS vs PMDD: When Luteal-Phase Mood Symptoms Need More Than Reassurance
- Endometriosis and Mental Health: How Inflammation Affects the Brain
- Progesterone and Fibroids: What to Monitor Before Starting Treatment
- Postpartum Thyroiditis: The Missed Driver of Anxiety and Depression
Related Episodes
FAQ
Yes. This episode explains that insulin often rises before glucose and A1C become abnormal. A patient may have higher hunger signals and find that fat loss feels harder even though routine diabetes screening still appears normal.
PMS causes premenstrual symptoms, but PMDD is more severe and can strongly disrupt mood, functioning, and safety. I describe PMDD as a disorder of hormone sensitivity and brain response rather than a simple problem of abnormal hormone levels.
Sometimes, yes, but the answer depends on the clinical picture. Fibroid size, location, bleeding pattern, pain, fertility goals, and the reason progesterone is being used all matter. The episode recommends monitoring with imaging and symptom tracking rather than relying on a blanket rule.
In the episode, I discuss supportive measures such as magnesium glycinate for sleep, iron repletion when blood loss has been significant, and nutrients such as omega-3s, vitamin D, and B12. Those measures can support recovery, but severe postpartum symptoms still require medical evaluation.
The episode explains that progesterone can slow motility during the luteal phase, while prostaglandins near menstruation can trigger cramping and looser stools. That pattern is common, but persistent or severe symptoms still need evaluation, especially in patients with IBD.
I highlight a postpartum panel that may include a CBC, ferritin, TSH, free T4, free T3, thyroid antibodies, vitamin D, and B12. Those labs can reveal thyroid disease, iron deficiency, or nutrient depletion that may be contributing to ongoing symptoms.